Detail page

Knowledge Web

Person

Patrick Nikolaus Harter (1980-)

Arzt

Name	Patrick Nikolaus Harter
Time	1980- (Date of birth and death)
Place	Böblingen (Geburtsort) Deutschland
Gender	männlich
Academic degree	Dr. med. (Universität Tübingen, Medizinische Fakultät) (2008) Dr. med. habil., Priv.-Doz. (Fachbereich Medizin der Johann Wolfgang Goethe-Universität Frankfurt am Main) (2016)
Profession	Arzt (characteristic profession)
Variant	Patrick Harter (Metadaten) Patrick N. Harter
Record type	Person
GND-Identifier	136226558
Record ID	136226558
Involved in show all Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology Klinische Bedeutung epigenetischer und genetischer Signaturen diffuser Gliome auf Grundlage globaler DNA-Methylierungsdaten The Acute Superficial Siderosis Syndrome — Clinical Entity, Imaging Findings, and Histopathology Charakterisierung des zellulären Mikromilieus in humanen Hirnmetastasen Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis The acute superficial siderosis syndrome — clinical entity, imaging findings, and histopathology Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1 Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1 A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy Association of isocitrate dehydrogenase (IDH) status with edema to tumor ratio and its correlation with immune infiltration in glioblastoma Association of Isocitrate Dehydrogenase (IDH) status with edema to tumor ratio and its correlation with immune infiltration in glioblastoma CD74 and CD44 expression on CTCs in cancer patients with brain metastasis Clinical outcome and risk factors of red blood cell transfusion in patients undergoing elective primary meningioma resection DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma Early and late postoperative seizures in meningioma patients and prediction by a recent scoring system Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy Impact and risk factors of red blood cell transfusion on patients undergoing elective primary meningioma resection Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients Matching quantitative MRI parameters with histological features of treatment-naïve IDH wild-type glioma Meningioma surgery in patients ≥70 years of age: clinical outcome and validation of the SKALE score Persistent bowel dysfunction after surgery for Hirschsprung's disease: a neuropathological perspective Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial TGF‐[beta] activates pericytes via induction of the epithelial to mesenchymal transition protein SLUG in glioblastoma The tumor microenvironment in preclinical models of brain metastasis with a focus on tumor-associated macrophages and microglia and effects of whole-brain radiotherapy Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death Cetuximab-mediated protection from hypoxia-induced cell death: implications for therapy sequence in colorectal cancer Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma Maintenance of energy homeostasis during calorically restricted ketogenic diet and fasting-MR-spectroscopic insights from the ERGO2 trial Mid-gestation lethality of Atxn2l-ablated mice Non-invasive measurement of drug and 2-HG signals using 19F and 1H MR spectroscopy in brain tumors treated with the mutant IDH1 inhibitor BAY1436032 TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases MYCN amplification drives an aggressive form of spinal ependymoma Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma Influence of pregnancy on glioma patients Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy Ceritinib-induced regression of an insulin-like growth factor-driven neuroepithelial brain tumor Ceritinib-induced regression of an insulin-like growth factor-driven neuroepithelial brain tumor Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Patrick Nikolaus Harter (1980-)

Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas

DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma

The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment

The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis

Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes

Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability

Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

Klinische Bedeutung epigenetischer und genetischer Signaturen diffuser Gliome auf Grundlage globaler DNA-Methylierungsdaten

The Acute Superficial Siderosis Syndrome — Clinical Entity, Imaging Findings, and Histopathology

Charakterisierung des zellulären Mikromilieus in humanen Hirnmetastasen

Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis

The acute superficial siderosis syndrome — clinical entity, imaging findings, and histopathology

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy

Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy

Association of isocitrate dehydrogenase (IDH) status with edema to tumor ratio and its correlation with immune infiltration in glioblastoma

Association of Isocitrate Dehydrogenase (IDH) status with edema to tumor ratio and its correlation with immune infiltration in glioblastoma

CD74 and CD44 expression on CTCs in cancer patients with brain metastasis

Clinical outcome and risk factors of red blood cell transfusion in patients undergoing elective primary meningioma resection

DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma

Early and late postoperative seizures in meningioma patients and prediction by a recent scoring system

Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy

Impact and risk factors of red blood cell transfusion on patients undergoing elective primary meningioma resection

Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients

Matching quantitative MRI parameters with histological features of treatment-naïve IDH wild-type glioma

Meningioma surgery in patients ≥70 years of age: clinical outcome and validation of the SKALE score

Persistent bowel dysfunction after surgery for Hirschsprung's disease: a neuropathological perspective

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial

TGF‐[beta] activates pericytes via induction of the epithelial to mesenchymal transition protein SLUG in glioblastoma

The tumor microenvironment in preclinical models of brain metastasis with a focus on tumor-associated macrophages and microglia and effects of whole-brain radiotherapy

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death

Cetuximab-mediated protection from hypoxia-induced cell death: implications for therapy sequence in colorectal cancer

Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features

Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma

Maintenance of energy homeostasis during calorically restricted ketogenic diet and fasting-MR-spectroscopic insights from the ERGO2 trial

Mid-gestation lethality of Atxn2l-ablated mice

Non-invasive measurement of drug and 2-HG signals using 19F and 1H MR spectroscopy in brain tumors treated with the mutant IDH1 inhibitor BAY1436032

TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma

Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases

MYCN amplification drives an aggressive form of spinal ependymoma

Lack of H3K27 trimethylation is associated with 1p/19q codeletion in diffuse gliomas

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma

Influence of pregnancy on glioma patients

Car-engineered nk cells for the treatment of glioblastoma: Turning innate effectors into precision tools for cancer immunotherapy

Ceritinib-induced regression of an insulin-like growth factor-driven neuroepithelial brain tumor

Ceritinib-induced regression of an insulin-like growth factor-driven neuroepithelial brain tumor

Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas

High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma